Share this page

 NATSIMLY — 2284237

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2284237

Registration number

TMA1355089

Type(s)

Standard Characters

Category

Trademark

CIPO Status

REGISTERED

TM5 status

LIVE/REGISTRATION/Issued and Active
The trademark application has been registered with the Office.

Filed

2023-09-28

Registered

2025-10-24

Registration Expiry Date

2035-10-24

Registered Owner

ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285
UNITED STATES OF AMERICA

Agent

BORDEN LADNER GERVAIS LLP
World Exchange Plaza
100 Queen Street, Suite 1300
Ottawa
ONTARIO K1P1J9

Documents

View documents

Index headings

  • NATSIMLY

Goods (Nice class & Statement)

5
(1) Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Action History

Actions
Action Action date Due date Comments
Filed 2023-09-28
Created 2023-09-28
Formalized 2023-09-28
Pre-Assessment Letter Sent 2023-10-12 Goods or Services Not Acceptable
Search Recorded 2025-06-27
Approved 2025-07-08 APPROVED BY PROGRAM EX200M1
Approval Notice Sent 2025-07-08 APPROVED BY PROGRAM EX200M1
Advertised 2025-08-06 Vol.72 Issue 3693
Registration Pending 2025-10-24
Registered 2025-10-24 2035-10-24
Report a problem on this page
Date modified: